Literature DB >> 19669030

[The age as a predictive factor in in vitro fertilization cycles].

Luiz Mauro Oliveira Gomes1, Aparecida Dos Santos Canha, Artur Dzik, Neil Ferreira Novo, Yara Juliano, Sandra Irene Sprogis Dos Santos, Mario Cavagna.   

Abstract

PURPOSE: to evaluate the patient's age as an outcome predictor in an in vitro fertilization (IVF) program.
METHODS: transversal study, which has included 302 women with ages varying from 24 to 46 years old, submitted to IVF, from May 2005 to July 2007. The patients were divided in three groups, according to their age: G<or=35 (n=161), G 36-39 (n=89) e G>or=40 (n=52). The number of collected oocytes, the fertilization rates, the number of transferred embryos, the embryonary quality and the pregnancy rate were evaluated. Statistical analysis was realized through Kruskal-Wallis variance analysis and chi(2) test.
RESULTS: in the G<or=35 group, an average of 8.8 oocytes by patient was obtained; in the G 36-49 group, 7.4; and in the G>or=40 group, 1.6. The number of oocytes obtained in G>or=40 group was significantly lower than in the other two groups (p<0.001).The fertilization rate was similar in the three groups, 61.4, 65.8 e 64.6% (p=0.2288), respectively. The percentage of good quality embryos was not statistically different among the three groups either, with rates of 57.4, 63.2 and 56.0% (p=0.2254), respectively. The average number of transferred embryos in each group was 3.1 (G<or=35), 2.8 (G 36-39) and 1.5 (G>or=40), respectively, with statistically significant decrease in the G>or=40 group (p<0.001). Concerning pregnancy rates, the G>or=40 group has presented a rate of 9.6%, a result which is significantly lower (p=0.0330) than the one presented by the G<or=35 and G 36-39 groups (26.1 e 27.0%, respectively), with no significant difference between themselves.
CONCLUSIONS: though the embryonary quality is not different among women from different age groups, the number of collected oocytes, the number of transferred embryos and the pregnancy rate indicate that the women's age is an important predictive factor of success for the techniques of assisted reproduction and should be taken into consideration when this kind of treatment is proposed to women over 40.

Entities:  

Mesh:

Year:  2009        PMID: 19669030     DOI: 10.1590/s0100-72032009000500005

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  5 in total

1.  Correlation of oocyte morphometry parameters with woman's age.

Authors:  Claudia Valeri; Sebastiana Pappalardo; Massimo De Felici; Claudio Manna
Journal:  J Assist Reprod Genet       Date:  2011-04-06       Impact factor: 3.412

2.  Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles.

Authors:  Ensieh Sh Tehraninejad; Elham Azimi Nekoo; Zahra Ezabadi; Batool H Rashidi; Elham Amirchaghmaghi; Elham Pour Matroud
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

3.  Does women's age influence zona pellucida birefringence of metaphase ΙΙ oocytes in in-vitro maturation program?

Authors:  Marjan Omidi; Mohammad Ali Khalili; Hossein Nahangi; Sareh Ashourzadeh; Marzieh Rahimipour
Journal:  Iran J Reprod Med       Date:  2013-10

4.  Assessment of mouse germinal vesicle stage oocyte quality by evaluating the cumulus layer, zona pellucida, and perivitelline space.

Authors:  Hong-Xia Zhou; Yu-Zhen Ma; Ying-Lei Liu; Ying Chen; Cheng-Jie Zhou; Sha-Na Wu; Jiang-Peng Shen; Cheng-Guang Liang
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization.

Authors:  Gen-Hong Mao; Zonggang Feng; Yan He; Yu-Rong Huang
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.